Financing

Alnylam Pharmaceuticals·Cash Flow Statement·10 metrics

Breakdown

Loading...

Metrics

Proceeds from liabilities related to the sale of future royalties and development funding

Other, net

Proceeds from liabilities related to the sale of future royalties and development funding

Repayment Of Liabilities Related To The Sale Of Future Royalties And Development Funding

Payment of Deferred Purchase Consideration

Noncontrolling interest transactions and other

Net cash from financing activities

Other financing activities

Noncontrolling Interests Activity and Other

Proceeds from issuance of common stock